Bone marrow cancer

Biocon inks patent litigation settlement pact with Celgene over bone marrow cancer medicine

The company along with its subsidiaries has entered into a confidential settlement agreement with Celgene Corporation, a wholly-owned subsidiary of Bristol Myers Squibb.

published on : 8th September 2021